This is out Library. Please click on the article title to view the details.
submitted by: admin on 10/14/2013
Merck wants to make Mevacor an over the counter drug. This would no doubt sell more drug, but also be giving a dangerous drug to people who do not need it. Its side effects are dangerous.
submitted by: admin on 04/12/2015
If you're going to take a medicine, it is also important to ask about side effects. MDs have a tendency to recommend a drug and not emphasize the possible side effects because it is not practical; there are just too many. If MDs disclosed all the complications of medications people would not want them; they'd be far more interested in lifestyle...
submitted by: admin on 11/05/2024
Combining SSRI antidepressants with aspirin or other NSAIDs can lead to a 42% increase risk for bleeding. SSRIs may inhibit the uptake and storage of serotonin by platelets. Low platelet serotonin leads to reduced platelet aggregation and a tendency to bleed.
Considering that SSRIs have little evidence that they work better than placebo and that...
submitted by: admin on 06/25/2016
Patients with advanced cancer have the mistaken belief that chemotherapy can cure their illness according to a New England Journal of Medicine article published in October of 2012. This Dana-Farber Cancer Institute study showe that 69% of advanced lung cancer and 81% of advanced colorectal cancer did not understand that chemotherapy was not at...
submitted by: admin on 10/16/2013
Statins were shown to be cancer producing in animals but may actually lower the risk in humans. Data shows a possible minor benefit in this regard but they should not be used for this purpose because of other side effects.
submitted by: admin on 10/16/2013
Statin usage is way overused in medical practice. These drugs have significant side effects that can severely compromise our health. Lifestyle is a superior way to manage arteriosclerosis.
submitted by: admin on 10/16/2013
Zometa, a bisphosphonate drug used to prevent bone metastases in women with breast cancer, was serendipitously found to reduce metastases and extend life by 37%. This translates to 4-5 out of 100 being alive 7 years later. An IV infusion was given every six months for 3 years. Cost is between $1500 and $2500 per injection. All patients were early-stage and had...
submitted by: admin on 10/16/2013
The largest study ever done on how we should treat hypertension showed that thiazide diuretics and lifestyle are what was recommended. It exposes the mercenary nature of big pharma in promoting their new designer drugs that work no better than older approaches that are cheap.
submitted by: admin on 04/12/2015
According to a collaborative study between the University of Texas Medical Center and UCSF Medical Center that was published in the Journal of the American Geriatric Society in June of 2014, people over the age of 65 who are treated with thiazide diuretics (such as HCTZ -- which is hydrochlorthiazide -- or Hygroton), are in danger of developing several...
submitted by: admin on 10/17/2013
The polypill is a brainstorm of the pharmaceutical companies to create a combination of drugs to make it convenient to take multiple medications. However, their real motive is to sell as much drug as possible. Consequently, they have done research under the guise of convenience but with the hope that they can convince the public and the medical profession to...
submitted by: admin on 10/17/2013
Roche pharmaceuticals, the manufacturer of Tamiflu, has refused for 3 years to release key data from their Tamiflu research trial that "justifies" its use in influenza to the prestigious Cochrane Review. What are they trying to hide? Why has the FDA, CDC, and WHO endorsed using Tamiflu within the first 48 hours of symptoms of the flu when...
submitted by: admin on 10/17/2013
SSRIs have been shown to be no better than placebo in a large metaanalysis. Psychiatry has taken a huge step backwards by turning to psychopharmacology. Treating symptoms rather than looking at the deeper causes of depression is naive except in rare occasions. Placebo is a powerful tool that evolkes the neurobiology of the body.
submitted by: admin on 01/09/2017
Lifestyle is a powerful antidote to inflammation. All the pharmaceutical drugs used to treat type 2 diabetes have significant side effects that are potentially serious. The common drug classes used to treat diabetes are reviewed. Some of these drugs increase the risk of heart attack and death by more than 50%.
submitted by: admin on 01/09/2017
This overview of Type II diabetes will help you understand how diabetes develops and what can be done to prevent or resolve it. Lifestyle strategies are discussed, as are drugs and supplements.
submitted by: admin on 10/17/2013
Mainstream medicine relies on drugs that have many dangerous side effects. There are simple nutritional approaches that can profoundly reduce symptoms and prevent relapses; they are discussed.
submitted by: admin on 04/14/2015
Over the years the way we evaluate and treat for hypertension has changed considerably. There has been a tendency to treat blood pressures that are greater than 140/90, but new data published in the January issue of the New England Journal of Medicine suggests that for people over the age of 60 suggests that BPs of 150/90 should no longer be treated with...
submitted by: admin on 02/16/2015
In the year 1980 there were 2.6 million deaths from measles in third world countries, primarily Africa and Asia, but by 2013 this number dropped to 146,000! This is likely the result of the vaccine and supplementation with vitamin A. There have been less than 10 deaths from measles in the US over the past several years. Measles is a disease that occurs in the...
submitted by: admin on 03/01/2015
SSRI antidepressants, according to research published in the February issue of Neuroscience and Biobehavioral Reviews, may increase serum levels of serotonin, but actually lower levels in the brain. This family of drugs blocks the re-uptake of serotonin by nerve tissue, which raises serum levels but actually lowers levels where we need them the most -- in...